Content about Diovan

January 3, 2013

Ranbaxy preserves exclusivity period for generic hypertension drug

A court has ruled in favor of Indian generic drug maker Ranbaxy Labs in a case concerning a generic blood pressure drug, the legal firm representing the drug maker said.

June 2, 2011

FDA: ARBs do not pose increased cancer risk

A class of drugs commonly used to control blood pressure does not increase patients’ risk of developing cancer, according to the Food and Drug Administration.